Literature DB >> 21561903

Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis.

Jasmine Lamba1, Christopher S Simpson, Damian P Redfearn, Kevin A Michael, Michael Fitzpatrick, Adrian Baranchuk.   

Abstract

AIMS: Sleep apnoea (SA) is a common problem among congestive heart failure (CHF) patients. Evidence has shown that cardiac resynchronization therapy (CRT) reduces morbidity and mortality associated with CHF. The aim of this paper was to review studies evaluating the reduction of the Apnoea-Hypopnoea Index (AHI) in patients with SA after treatment with CRT and to perform a meta-analysis to estimate the true effect of CRT on SA. METHODS AND
RESULTS: A systematic electronic literature search was conducted in Medline and Embase to identify studies reporting on the effects of CRT on SA. A hand search of five major cardiology societies was performed to identify any unpublished studies through structured abstracts submitted to conference proceedings. To be eligible for inclusion, studies had to include a comparison of CRT vs. no pacing and use AHI as an outcome. Non-English studies were excluded. Nine manuscripts and five abstracts were identified for review. Six manuscripts and three abstracts were included in meta-analysis, which included 170 patients. After treatment with CRT, a significant reduction in AHI was found in patients with central sleep apnoea (CSA) with a mean reduction of -13.05 (CI -16.74 to -9.36; P < 0.00001) but not in patients with obstructive sleep apnoea (13.32; CI -9.04 to 2.39; P = 0.25).
CONCLUSION: Cardiac resynchronization therapy reduces the severity of SA. Major effects are seen in patients with CSA. The presence of SA may be an additional consideration when deciding on which heart failure patients will receive CRT.

Entities:  

Mesh:

Year:  2011        PMID: 21561903     DOI: 10.1093/europace/eur128

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  15 in total

Review 1.  Altered breathing syndrome in heart failure: newer insights and treatment options.

Authors:  Yasuhiro Tomita; Takatoshi Kasai; Tomohiko Kisaka; Harry B Rossiter; Yasuki Kihara; Karlman Wasserman; Hiroyuki Daida
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 2.  Heart failure and sleep disorders.

Authors:  Gianfranco Parati; Carolina Lombardi; Francesco Castagna; Paola Mattaliano; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Nat Rev Cardiol       Date:  2016-05-12       Impact factor: 32.419

3.  [Sleep-disordered breathing and cardiac resynchronization therapy].

Authors:  A-M Sinha
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

Review 4.  Heart failure and sleep disordered breathing.

Authors:  Akiomi Yoshihisa; Yasuchika Takeishi
Journal:  Fukushima J Med Sci       Date:  2017-07-21

Review 5.  Obstructive Sleep Apnea Syndrome as a Trigger of Cardiac Arrhythmias.

Authors:  Julio Martí-Almor; Jesús Jiménez-López; Benjamin Casteigt; Javier Conejos; Ermengol Valles; Núria Farré; Miquel Félez Flor
Journal:  Curr Cardiol Rep       Date:  2021-02-20       Impact factor: 2.931

Review 6.  Arrhythmia risk associated with sleep disordered breathing in chronic heart failure.

Authors:  Reena Mehra; Susan Redline
Journal:  Curr Heart Fail Rep       Date:  2014-03

7.  Therapy for sleep hypoventilation and central apnea syndromes.

Authors:  Bernardo J Selim; Mithri R Junna; Timothy I Morgenthaler
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

8.  Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene?

Authors:  Ali Valika; Maria Rosa Costanzo
Journal:  Card Fail Rev       Date:  2017-11

Review 9.  Management of Sleep Disordered Breathing in Patients with Heart Failure.

Authors:  Connor P Oates; Manjula Ananthram; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 10.  Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients.

Authors:  Karan R Chadda; Ibrahim T Fazmin; Shiraz Ahmad; Haseeb Valli; Charlotte E Edling; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Sleep       Date:  2018-09-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.